111 related articles for article (PubMed ID: 15770889)
21. Infections associated with solid malignancies.
Sutton SH
Cancer Treat Res; 2014; 161():371-411. PubMed ID: 24706232
[TBL] [Abstract][Full Text] [Related]
22. [Purulent pleurisy and lung cancer. Non-iatrogenic forms and therapeutic management].
Riquet M; Hubsch JP; Le Pimpec Barthes F; Abitbol P; Souilamas R; Zukerman C; Manac'h D
Rev Mal Respir; 1999 Nov; 16(5):817-22. PubMed ID: 10612151
[TBL] [Abstract][Full Text] [Related]
23. Bronchogenic carcinoma associated with upper aerodigestive cancers.
Yellin A; Hill LR; Benfield JR
J Thorac Cardiovasc Surg; 1986 May; 91(5):674-83. PubMed ID: 3702476
[TBL] [Abstract][Full Text] [Related]
24. The infectious complications of chronic lymphocytic leukemia.
Morrison VA
Semin Oncol; 1998 Feb; 25(1):98-106. PubMed ID: 9482531
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.
Nieboer P; de Vries EG; Mulder NH; Rodenhuis S; Bontenbal M; van der Wall E; van Hoesel QG; Smit WM; Hupperets P; Voest EE; Nooij MA; Boezen HM; van der Graaf WT
Bone Marrow Transplant; 2008 Oct; 42(7):475-81. PubMed ID: 18622420
[TBL] [Abstract][Full Text] [Related]
26. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
[TBL] [Abstract][Full Text] [Related]
27. Periodontal infection in cancer patients treated with high-dose chemotherapy.
Raber-Durlacher JE; Epstein JB; Raber J; van Dissel JT; van Winkelhoff AJ; Guiot HF; van der Velden U
Support Care Cancer; 2002 Sep; 10(6):466-73. PubMed ID: 12353125
[TBL] [Abstract][Full Text] [Related]
28. Trends in infections in children with malignant disease in 2000: comparison of data of 1980/81.
Laws HJ; Schneider DT; Janssen G; Wessalowski R; Dilloo D; Meisel R; Adams O; Mackenzie C; Göbel U
Pediatr Hematol Oncol; 2007; 24(5):343-54. PubMed ID: 17613879
[TBL] [Abstract][Full Text] [Related]
29. Rituximab-associated infections.
Gea-Banacloche JC
Semin Hematol; 2010 Apr; 47(2):187-98. PubMed ID: 20350666
[TBL] [Abstract][Full Text] [Related]
30. [Radiochemotherapy in non-small-cell lung cancer].
Swartman B
Med Klin Intensivmed Notfmed; 2011 Nov; 106(3):212-7. PubMed ID: 22068757
[No Abstract] [Full Text] [Related]
31. Breakdown of pulmonary host defense in the immunocompromised host: cancer chemotherapy.
Joos L; Tamm M
Proc Am Thorac Soc; 2005; 2(5):445-8. PubMed ID: 16322598
[TBL] [Abstract][Full Text] [Related]
32. [Central nervous system infections in patients with malignant diseases].
Carpentier AF; Bernard L; Poisson M; Delattre JY
Rev Neurol (Paris); 1996 Oct; 152(10):587-601. PubMed ID: 9033951
[TBL] [Abstract][Full Text] [Related]
33. [To be cured of lung cancer].
Depierre A; Jacoulet P; Westeel V; Falcoz PE
Bull Cancer; 2002 Apr; 89(4):351-6. PubMed ID: 12016035
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis and management of central nervous system infections in pediatric cancer patients].
Hernárz Driever P; Reich S
Klin Padiatr; 2005 Nov; 217 Suppl 1():S120-9. PubMed ID: 16288358
[TBL] [Abstract][Full Text] [Related]
35. The impact of the host on fungal infections.
Perfect JR
Am J Med; 2012 Jan; 125(1 Suppl):S39-51. PubMed ID: 22196208
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
Grossi F; Tiseo M
Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
[TBL] [Abstract][Full Text] [Related]
37. [Follow-up, complications and their treatment in the surgical, radiotherapeutic and pharmacological treatment of lung cancer].
Armbrecht A; Gröschel A; Pöttgen C; Reck M; Rüffer JU; Seifart U; Ulrich CM; Winter H
Onkologie; 2011; 34 Suppl 4():11-6. PubMed ID: 21677468
[No Abstract] [Full Text] [Related]
38. Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.
Hathorn JW
Hematol Oncol Clin North Am; 1993 Oct; 7(5):1051-99. PubMed ID: 8226565
[TBL] [Abstract][Full Text] [Related]
39. [Clinical practice guideline for lung cancer].
Hayakawa K; Tsuboi M
Gan To Kagaku Ryoho; 2010 Apr; 37(4):609-12. PubMed ID: 20414015
[TBL] [Abstract][Full Text] [Related]
40. [Lung cancer management does not limit itself to anticancer treatments].
Margery J
Rev Pneumol Clin; 2008 Apr; 64(2):47-8. PubMed ID: 18589283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
